Varicella zoster virus (VZV) is the causative agent of chicken pox and shingles. The overall objective of this proposal is to understand the nature of physical and functional interactions between the complex VZV major transactivator, IE62, and specific components of the cellular transcription apparatus. Such information is critical to our understanding of the complex pathogenesis of VZV infection. It is particularly important in terms of the live attenuated VZV vaccine. Vaccination is now recommended for all children and recently the FDA approved the vaccine for use in the elderly for the prevention of zoster based on an extensive clinical trial. Currently little is known concerning attenuation of the vaccine virus. Since the IE62 gene accumulates the majority of mutations in the attenuated vaccine strains, understanding its interaction with host functions could lead to the development of second generation vaccine whose molecular mechanism of attenuation is well understood. The work proposed involves three Specific Aims.
Specific Aim 1 : Functional Interaction of IE62 with Cellular Factors. We will examine the functional interaction between the IE62 protein and two essential cellular transcription factors the Mediator complex and HCF-1. This will be done by mapping and mutation of interacting domains and expression of these mutations in the context of the viral genome.
Specific Aim 2 : Role of DNA Binding in the Mechanism of IE62 Activation. We will determine the specificity and affinity of the IE62- DNA Interaction and the effect of mutations in the DNA-binding domain on IE62 DNA-binding and transactivation and viral gene expression.
Specific Aim 3 : Interrelationship Between IE62 Structure and Function. We will mutate the IE62 SEAC domains and assess there function in in vitro transcription assays. The growth properties of virus carrying mutations in these domains will be determined. We will determine if the two transcriptional activation domains present in the IE62 homodimer are both required for IE62 function and what functions they perform. These studies will help us to understand the ways in which this important viral protein influences the functions of cells following infection. Since the live attenuated VZV vaccine will be used to prevent chicken pox and shingles throughout the U.S. population it is important to understand how the virus interacts with its human host. This work should also result in information that could be used in strategies to develop better anti-viral drugs and vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56AI018449-25A2
Application #
7650865
Study Section
Virology - B Study Section (VIRB)
Program Officer
Beisel, Christopher E
Project Start
1982-08-01
Project End
2012-12-31
Budget Start
2008-08-01
Budget End
2012-12-31
Support Year
25
Fiscal Year
2008
Total Cost
$393,533
Indirect Cost
Name
State University of New York at Buffalo
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Khalil, Mohamed I; Che, Xibing; Sung, Phillip et al. (2016) Mutational analysis of varicella-zoster virus (VZV) immediate early protein (IE62) subdomains and their importance in viral replication. Virology 492:82-91
Khalil, Mohamed I; Sommer, Marvin H; Hay, John et al. (2015) Varicella-zoster virus (VZV) origin of DNA replication oriS influences origin-dependent DNA replication and flanking gene transcription. Virology 481:179-86
Khalil, Mohamed I; Ruyechan, William T; Hay, John et al. (2015) Differential effects of Sp cellular transcription factors on viral promoter activation by varicella-zoster virus (VZV) IE62 protein. Virology 485:47-57
Khalil, Mohamed I; Sommer, Marvin; Arvin, Ann et al. (2014) Cellular transcription factor YY1 mediates the varicella-zoster virus (VZV) IE62 transcriptional activation. Virology 449:244-53
Khalil, Mohamed I; Sommer, Marvin; Arvin, Ann et al. (2013) Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors. Virology 440:171-81
Khalil, Mohamed I; Robinson, Makeda; Sommer, Marvin et al. (2012) An Sp1/Sp3 site in the downstream region of varicella-zoster virus (VZV) oriS influences origin-dependent DNA replication and flanking gene transcription and is important for VZV replication in vitro and in human skin. J Virol 86:13070-80
Khalil, Mohamed I; Arvin, Ann; Jones, Jeremy et al. (2011) A sequence within the varicella-zoster virus (VZV) OriS is a negative regulator of DNA replication and is bound by a protein complex containing the VZV ORF29 protein. J Virol 85:12188-200
Ruyechan, William T (2010) Roles of cellular transcription factors in VZV replication. Curr Top Microbiol Immunol 342:43-65
White, Kris; Peng, Hua; Hay, John et al. (2010) Role of the IE62 consensus binding site in transactivation by the varicella-zoster virus IE62 protein. J Virol 84:3767-79
Yamamoto, Shinobu; Eletsky, Alexander; Szyperski, Thomas et al. (2009) Analysis of the varicella-zoster virus IE62 N-terminal acidic transactivating domain and its interaction with the human mediator complex. J Virol 83:6300-5